0

Journal Articles

in Cardiovascular Disease Prevention
 21-40 of 147 Articles
Research Letters |  September 10, 2012
Evaluation of Sodium Levels in Hospital Patient Menus
JoAnne Arcand, PhD, RD; Katherine Steckham; Roula Tzianetas, MSc, RD; et al.
Arch Intern Med. 2012;172(16):1261-1262. doi:10.1001/archinternmed.2012.2368.
Invited Commentary |  September 10, 2012
A Call to Our Hospitals: Please Hold the Salt!:  Comment on “Evaluation of Sodium Levels in Hospital Patient Menus”
Kirsten Bibbins-Domingo, PhD, MD, MAS
Arch Intern Med. 2012;172(16):1262-1263. doi:10.1001/archinternmed.2012.3466.
Invited Commentary |  July 23, 2012
Loneliness and Living Alone:  Comment on “Loneliness in Older Persons” and “Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis”
Emily M. Bucholz, MPH; Harlan M. Krumholz, MD, SM
Arch Intern Med. 2012;172(14):1084-1085. doi:10.1001/archinternmed.2012.2649.
Original Investigation |  July 23, 2012
Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis
Jacob A. Udell, MD, MPH; Philippe Gabriel Steg, MD; Benjamin M. Scirica, MD, MPH; et al.
Arch Intern Med. 2012;172(14):1086-1095. doi:10.1001/archinternmed.2012.2782.
Invited Commentary |  June 25, 2012
Statins Work Just as Well in Women as in Men:  Comment on “Statin Therapy in the Prevention of Recurrent Cardiovascular Events”
Fiona Taylor, PhD, HonMFPH; Shah Ebrahim, DM, FRCP
Arch Intern Med. 2012;172(12):919-920. doi:10.1001/archinternmed.2012.2434.
Invited Commentary |  May 14, 2012
Omega-3 Fatty Acids and Secondary Prevention of Cardiovascular Disease—Is It Just a Fish Tale?:  Comment on “Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease”
Frank B. Hu, MD, PhD; JoAnn E. Manson, MD, DrPH
Arch Intern Med. 2012;172(9):694-696. doi:10.1001/archinternmed.2012.463.
Special Article |  April 23, 2012
Cardiovascular Primary Prevention:  How High Should We Set the Bar?
Vinay Prasad, MD; Andrae Vandross, MD
Arch Intern Med. 2012;172(8):656-659. doi:10.1001/archinternmed.2012.812.
Editor's Correspondence |  March 26, 2012
Cardiovascular Risk Evaluation Tools Specific to Population With Diabetes
Justin Basile Echouffo-Tcheugui, MD, PhD; Eugene Sobngwi, MD, PhD; Andre Pascal Kengne, MD, PhD
Arch Intern Med. 2012;172(6):523-524. doi:10.1001/archinternmed.2011.1870.
Editor's Correspondence |  March 26, 2012
Cardiovascular Risk Evaluation Tools Specific to Population With Diabetes—Reply
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Nancy R. Cook, ScD
Arch Intern Med. 2012;172(6):523-524. doi:10.1001/archinternmed.2012.49.
Review Article |  November 14, 2011 FREE
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction:  A Systematic Review and Meta-analysis
Bhanu P. Gupta, MD; M. Hassan Murad, MD; Marisa M. Clifton, MD; et al.
Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.
INCLUDES: , Supplemental Content
Invited Commentary |  October 24, 2011
Cardiovascular Risk Stratification, Hemoglobin A1c, and the Tempo of Translation:  Comment on “Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent”
Mark J. Pletcher, MD, MPH
Arch Intern Med. 2011;171(19):1718-1720. doi:10.1001/archinternmed.2011.352.
Original Investigation |  October 24, 2011 FREE
Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Aruna D. Pradhan, MD; et al.
Arch Intern Med. 2011;171(19):1712-1718. doi:10.1001/archinternmed.2011.351.
INCLUDES: , Supplemental Content
Review Article |  September 12, 2011 FREE
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors:  A Systematic Review and Meta-analysis of Randomized Trials
Valérie Santschi, PharmD, PhD; Arnaud Chiolero, MD, MSc; Bernard Burnand, MD, MPH; et al.
Arch Intern Med. 2011;171(16):1441-1453. doi:10.1001/archinternmed.2011.399.
Editor's Correspondence |  September 12, 2011
Hypoglycemia Associated With Impaired Renal Function
Adam M. Ali, BA(Cantab)
Arch Intern Med. 2011;171(16):1512. doi:10.1001/archinternmed.2011.378.
Correction |  July 25, 2011
Last-minute Change in June 27 Table of Contents
Arch Intern Med. 2011;171(14):1224. doi:10.1001/archinternmed.2011.366.
Original Investigation |  May 23, 2011 FREE
Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention
Terri R. Fried, MD; Mary E. Tinetti, MD; Virginia Towle, MPhil; et al.
Arch Intern Med. 2011;171(10):923-928. doi:10.1001/archinternmed.2011.32.
Invited Commentary |  March 14, 2011
Diabetes and Cardiovascular Risk Equivalency: Do Age at Diagnosis and Disease Duration Affect Risk Stratification?:  Comment on “Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men”
Iskandar Idris, DM, FRCP
Arch Intern Med. 2011;171(5):410-411. doi:10.1001/archinternmed.2010.524.
Articles |  February 28, 2011
Error in Wording in: Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Arch Intern Med. 2011;171(4):305. doi:10.1001/archinternmed.2010.546.
Original Investigation |  February 14, 2011 FREE
Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
Stephanie R. Earnshaw, PhD; James Scheiman, MD; A. Mark Fendrick, MD; et al.
Arch Intern Med. 2011;171(3):218-225. doi:10.1001/archinternmed.2010.525.
INCLUDES: , Supplemental Content
Editor's Correspondence |  December 13, 2010
Statins and All-Cause Mortality in High-Risk Primary Prevention of Patients With Cardiovascular Risk Factors
Jasper Jan Brugts, MD, PhD, MSc; Jaap W. Deckers, MD, PhD
Arch Intern Med. 2010;170(22):2041. doi:10.1001/archinternmed.2010.455.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Original Contribution  |  June 12, 2013
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Melissa M. Hudson, MD; Kirsten K. Ness, PT, PhD; James G. Gurney, PhD; et al.
JAMA
Original Contribution  |  May 15, 2013
Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
Pamela N. Peterson, MD, MSPH; Paul D. Varosy, MD; Paul A. Heidenreich, MD; et al.
JAMA
Original Contribution  |  May 08, 2013
Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery:  The ADVANCE III Randomized Clinical Trial
Maurizio Gasparini, MD; Alessandro Proclemer, MD; Catherine Klersy, MD, MSc; et al.
JAMA
Viewpoint  |  March 25, 2013
Combination Therapy to Prevent Cardiovascular Disease:  Slow Progress
Richard Smith, MB, ChB, MSc, FRCPE; Tara McCready, MBA, PhD; Salim Yusuf, DPhil, FRCPC, FRSC
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems